Treatment options for small cell lung cancer – do we have more choice?

por Puglisi, M, Dolly, S, Faria, A, Myerson, J S, Popat, S, O'Brien, M E R
Publicado 2010

Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer

por Ng, K, Wolpin, B M, Meyerhardt, J A, Wu, K, Chan, A T, Hollis, B W, Giovannucci, E L, Stampfer, M J, Willett, W C, Fuchs, C S
Publicado 2010

MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea

por McDaid, J R, Loughery, J, Dunne, P, Boyer, J C, Downes, C S, Farber, R A, Walsh, C P
Publicado 2010

Reply: Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors

por Novello, S, Scagliotti, G V, Rosell, R, Socinski, M A, Brahmer, J, Atkins, J, Pallares, C, Burgess, R, Tye, L, Selaru, P, Wang, E, Chao, R, Govindan, R
Publicado 2010

Regarding: ‘Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array’

por Pander, J, Gelderblom, H, van der Straaten, T, Punt, C J A, Guchelaar, H-J
Publicado 2010

Myelosuppression by sunitinib is flt-3 genotype dependent

por van Erp, N P, Mathijssen, R H J, van der Veldt, A A, Haanen, J B, Reyners, A K L, Eechoute, K, Boven, E, Wessels, J A M, Guchelaar, H-J, Gelderblom, H
Publicado 2010

Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England

por Howell-Jones, R, Bailey, A, Beddows, S, Sargent, A, de Silva, N, Wilson, G, Anton, J, Nichols, T, Soldan, K, Kitchener, H
Publicado 2010

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma

por Maréchal, R, Demetter, P, Nagy, N, Berton, A, Decaestecker, C, Polus, M, Closset, J, Devière, J, Salmon, I, Van Laethem, J-L
Publicado 2010

Pooled analysis of recent studies of magnetic fields and childhood leukaemia

por Kheifets, L, Ahlbom, A, Crespi, C M, Draper, G, Hagihara, J, Lowenthal, R M, Mezei, G, Oksuzyan, S, Schüz, J, Swanson, J, Tittarelli, A, Vinceti, M, Wunsch Filho, V
Publicado 2011

Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma

por Bozzetti, C, Negri, F V, Lagrasta, C A, Crafa, P, Bassano, C, Tamagnini, I, Gardini, G, Nizzoli, R, Leonardi, F, Gasparro, D, Camisa, R, Cavalli, S, Silini, E M, Ardizzoni, A
Publicado 2011

Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer

por Xiang, R, Liao, D, Cheng, T, Zhou, H, Shi, Q, Chuang, T H, Markowitz, D, Reisfeld, R A, Luo, Y
Publicado 2011

Reply: Flawed methods explain the effect of mammography screening in Nijmegen

por Verbeek, A L M, Broeders, M J M, van Schoor, G, Moss, S M, Otten, J D M, Donders, R, Paap, E, den Heeten, G J, Holland, R
Publicado 2011

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers

por Harrington, K J, Billingham, L J, Brunner, T B, Burnet, N G, Chan, C S, Hoskin, P, Mackay, R I, Maughan, T S, Macdougall, J, McKenna, W G, Nutting, C M, Oliver, A, Plummer, R, Stratford, I J, Illidge, T
Publicado 2011

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer

por Khan, O A, Blann, A D, Payne, M J, Middleton, M R, Protheroe, A S, Talbot, D C, Taylor, M, Kirichek, O, Han, C, Patil, M, Harris, A L
Publicado 2011

Personalised cancer follow-up: risk stratification, needs assessment or both?

por Watson, E K, Rose, P W, Neal, R D, Hulbert-Williams, N, Donnelly, P, Hubbard, G, Elliott, J, Campbell, C, Weller, D, Wilkinson, C
Publicado 2012

Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation

por Boykin, C, Zhang, G, Chen, Y-H, Zhang, R-W, Fan, X-E, Yang, W-M, Lu, Q
Publicado 2012

Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate

por Khan, O A, Blann, A D, Payne, M J, Middleton, M R, Protheroe, A S, Talbot, D C, Taylor, M, Han, C, Patil, M, Harris, A L
Publicado 2012

Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor negative breast cancer

por Ohotski, J, Long, J S, Orange, C, Elsberger, B, Mallon, E, Doughty, J, Pyne, S, Pyne, N J, Edwards, J
Publicado 2012

Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma

por Sonpavde, G, Choueiri, T K
Publicado 2012

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome

por Ryan, J, Tivnan, A, Fay, J, Bryan, K, Meehan, M, Creevey, L, Lynch, J, Bray, I M, O'Meara, A, Tracey, L, Davidoff, A M, Stallings, R L
Publicado 2012